What is pneumonic plague?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pneumonic Plague: The Most Lethal Form of Plague

Pneumonic plague is the most dangerous and fatal form of plague, characterized by severe pneumonia with high fever, dyspnea, and often hemoptysis, with nearly 100% mortality if not treated within 18 hours of symptom onset. 1

Definition and Causative Agent

Pneumonic plague is caused by Yersinia pestis, a gram-negative coccobacillus belonging to the Enterobacteriaceae family. This bacterium possesses several chromosomal and plasmid-associated factors essential for its virulence and survival in hosts and vectors 1.

Transmission

Pneumonic plague can occur in two ways:

  • Primary pneumonic plague: Results from direct inhalation of infectious respiratory droplets or aerosols from humans or animals with plague pneumonia 1, 2
  • Secondary pneumonic plague: Develops as a complication of bubonic or septicemic plague when the infection spreads to the lungs 1

Clinical Presentation

Pneumonic plague presents with:

  • Severe pneumonia
  • High fever
  • Respiratory distress (dyspnea)
  • Hemoptysis (coughing up blood)
  • Rapid progression of symptoms 1, 2

The disease is characterized by:

  • Short incubation period of 1-3 days
  • Extremely rapid disease progression
  • Respiratory and circulatory failure if untreated 1, 3

Pathophysiology

The disease progression follows a distinct pattern:

  1. Initial rapid bacterial replication in the lungs without obvious symptoms
  2. Sudden onset of a severe inflammatory response
  3. Quick progression to respiratory failure 4

Epidemiology

Pneumonic plague is the least common but most lethal form of plague:

  • Accounts for a small percentage of plague cases globally
  • Has been documented in recent outbreaks, including in Uganda in 2006 where 12% of 102 documented plague cases were pneumonic 5
  • Can cause localized outbreaks with high mortality 1

Diagnosis

Diagnosis is based on:

  • Clinical presentation (severe pneumonia with rapid onset)
  • Epidemiological context (exposure to infected individuals or animals)
  • Laboratory confirmation through isolation of Y. pestis from sputum or blood 1

Treatment

Immediate antibiotic treatment is critical and must be initiated within 18 hours of symptom onset to prevent death. 1

Effective antibiotics include:

  • Streptomycin (considered the drug of choice)
  • Chloramphenicol
  • Doxycycline
  • Gentamicin
  • Ciprofloxacin 6

Public Health Implications

Pneumonic plague has significant public health implications:

  • It is the only form of plague that can be transmitted directly from person to person via respiratory droplets
  • Has potential for use as a biological weapon due to its high lethality and aerosol transmission 3, 2
  • Requires immediate reporting to public health authorities 1

Prevention

Prevention measures include:

  • Rapid identification and isolation of cases
  • Respiratory droplet precautions for healthcare workers
  • Prophylactic antibiotics for close contacts
  • Surveillance in endemic areas 1

Key Distinctions from Other Forms of Plague

Unlike bubonic plague (characterized by lymphadenopathy) and septicemic plague (characterized by bloodstream infection), pneumonic plague:

  • Has the shortest incubation period (1-3 days)
  • Progresses most rapidly
  • Has the highest mortality rate (approaching 100% if untreated)
  • Is the only form directly transmissible between humans 1, 2

Critical Warning Signs

Healthcare providers should be alert to:

  • Clusters of severe pneumonia cases with rapid progression
  • Pneumonia in patients with potential exposure to plague
  • Failure to respond to standard pneumonia treatments 1

The extremely short window for effective treatment (less than 18 hours after symptom onset) makes immediate recognition and intervention critical for survival 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pneumonic Plague: The Darker Side of Yersinia pestis.

Trends in microbiology, 2016

Research

Bubonic and pneumonic plague - Uganda, 2006.

MMWR. Morbidity and mortality weekly report, 2009

Research

[Yersinia pestis and plague - an update].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.